ArticleBMC urology2017
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients.
Yoshiyuki Miyazawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it